Task A: Early Phase Clinical Trial Units (EPCTU)

NIH RePORTER · NIH · N01 · $212,105 · view on reporter.nih.gov ↗

Abstract

The Early Phase Clinical Trial Units provide a vehicle for investigation of new agents in the treatment and prevention of infectious diseases and can carry out all aspects of interventional clinical trial implementation.

Key facts

NIH application ID: 11042110
Project number: 75N93022D00016-P00002-759302200001-1
Recipient: DYNPORT VACCINE COMPANY, LLC
Principal Investigator: GEORGE SAVIOLAKIS
Activity code: N01
Funding institute: NIH
Fiscal year: 2024
Award amount: $212,105
Award type: —
Project period: 2022-01-14 → 2025-01-13